会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明专利
    • NEW FORM III OF DOXAZOSIN MESYLATE
    • JPH10182641A
    • 1998-07-07
    • JP36407197
    • 1997-12-17
    • HEUMANN PHARMA GMBH & CO
    • GRAFE INGOMARMOERSDORF JOHANN PETER
    • A61K31/505A61P9/12A61P13/02A61P15/00C07D405/12
    • PROBLEM TO BE SOLVED: To obtain a crystalline anhydride of the subject compound useful for treating hypertension and benign prostomegaly, by taking a specific crystal form so as to be easily synthesizable, capable of realizing its high purity and water solubility, and also capable of advantageously producing solid preparations such as tablets or capsules. SOLUTION: This crystalline anhydride of doxazosin mesylate is in a form giving such power X-ray pattern as to have peaks of high or medium intensity at diffraction angles of 8.49 deg., 11.72 deg., 16.03 deg., 18.29 deg., 21.03 deg., 22.87 deg. and 25.02 deg., being obtained, for example, by the following process, that is, basic doxazosin is converted to doxazosin acetate by acetic acid in an organic solvent, the resultant solution is clarified in a hot state and then mixed with methanesulfonic acid followed by agitating the solution at a temperature ranging from 30 deg.C to the boiling point of the solvent; the resultant solvent adduct is collected through filtration, and, in a wet state, put into a lower alcohol, heated at the boiling point for 10min to 12hr, and then cooled to room temperature; and the resulting precipitated crystal is collected through filtration.
    • 8. 发明专利
    • NEW FORM II OF DOXAZOSIN MESYLATE
    • JPH10182640A
    • 1998-07-07
    • JP36407097
    • 1997-12-17
    • HEUMANN PHARMA GMBH & CO
    • GRAFE INGOMARMOERSDORF JOHANN PETER
    • A61K31/505A61P13/02A61P15/00C07D405/12
    • PROBLEM TO BE SOLVED: To obtain a crystalline anhydride of the subject compound useful for treating hypertension and benign prostomegaly, by taking a specific crystal form so as to be easily synthesizable, capable of realizing its high purity and water solubility, and also capable of advantageously producing solid preparations such as tablets or capsules. SOLUTION: This crystalline anhydrous doxazosin mesylate is in a form giving such power X-ray pattern as to have peaks of high or medium intensity at diffraction angles of 10.68 deg., 14.45 deg., 17.37 deg., 23.45 deg., 23.82 deg., and 24.30 deg., being obtained, for example, by the following process, that is, basic doxazosin A1 is suspended in a lower ketone followed by addition of a weak acid and, optionally, methanesulfonic acid A2 in an amount below equimolar level to form a water-soluble salt of A1 with the weak acid and/or a salt of part of A1 with A2 followed by adding A2 and a base to the system to adjust pH2-4 to effect precipitation of doxazosin mesylate, and the precipitate is collected through filtration, washed with an organic solvent, and then dried.